1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > CNS Drug News 01 FEBRUARY 2016

CNS Drug News 01 FEBRUARY 2016

  • February 2016
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Dynamics Within Industry-Academia Partnerships Changing
Industry Brief - Ntcell Continues To Stop PD Progression One Year After Implant
Industry Brief - Amarantus Secures Chinese Patent Covering Use Of MANF For PD
Industry Trend Analysis - Alkermes Trial Failures Raise MDD Development Doubts
Industry Trend Analysis - Breakthrough Designation For Rapastinel Enhances Competitive Position
Industry Brief - Neos' Adzenys XR-ODT FDA-Approved To Treat ADHD
Industry Brief - Trevena Initiated Oliceridine Phase III Programme In Acute Pain
Industry Brief - Dr Reddy's Gains FDA Sumatriptan Approval
Industry Brief - First Patient Dosed In Meloxicam Phase III Trial
Industry Brief - FDA Approves Onzetra Xsail To Treat Acute Migraine In Adults
Industry Brief - FDA Approves Onzetra Xsail For Acute Migraine In Adults
Industry Brief - Braeburn/Knight Sign Canadian Probuphine Licensing Deal
Industry Brief - Akorn Launches Buprenorphine/Naloxone Tablets And Tobramycin Injection
Industry Brief - Zogenix' ZX008 Gains FDA Fast Track Designation For Dravet Syndrome
Industry Brief - Mylan Launches Felbamate Tablets
Industry Trend Analysis - Briviact Approval Maintains UCB's Epilepsy Focus
Industry Brief - Aprecia Raises Funds To Advance Commercialisation Of 3D Printed Spritam
Industry Trend Analysis - Patient Risk Profile Key For Beloranib Success
Industry Trend Analysis - Need For CNS Therapies Continues To Attract Research Agreements
Industry Brief - FDA Approves Botox For Lower Limb Spasticity In Adults
Industry Brief - vasopharm Raises Funds For Phase III Study Of VAS203 In TBI
Industry Trend Analysis - J&J Focusing On Long-Term Neuroscience Performance
Industry Trend Analysis - Diversification Key To Overcoming Tecfidera Reliance

Table Of Contents

CNS Drug News 01 FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

  • $ 2995
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. ...

Chronic Spinal Cord Injury Global Clinical Trials Review, H2, 2016

Chronic Spinal Cord Injury Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Chronic Spinal Cord Injury Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Chronic Spinal Cord Injury Global Clinical Trials Review, H2, 2016" provides an overview ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the UK

  • December 2016
    194 pages
  • Therapy  

    Infectious Dise...  

    Eye Disease  

  • United Kingdom  

View report >

Therapy Market in the UK

  • November 2016
    16 pages
  • Therapy  

  • United Kingdom  

View report >

Global Therapy Market

  • November 2016
    12 pages
  • Vaccine  

  • Japan  

    World  

View report >

Related Market Segments :

Neurological Disorder

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.